ArticleAnnals of surgical oncology2025
MarginView3D: A Novel Software Enabling Comprehensive Three-Dimensional Surgical Pathology Documentation for Improved Intra- and Postoperative Cancer Care.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurgical pathology reports are crucial to the delivery of personalized and coordinated cancer management. However, traditional reports often lack clarity and comprehensiveness, which can lead to misinterpretation or suboptimal therapeutic planning. To address these issues, we developed MarginView3D
methodsWe detail the internally developed MV3D surgical pathology reporting platform created by a multidisciplinary team incorporating open-source platforms, commercial 3D scanners, and medical illustrators. This software was piloted in 26 head and neck cancer cases over 6 months.
resultsThe software facilitates comprehensive margin mapping and pathology reporting in a range of procedures: palatomaxillectomy (n = 5), parotidectomy (n = 5), mandibulectomy (n = 5), oral cavity soft tissue resection (n = 5), laryngectomy/laryngopharyngectomy (n = 4), thyroidectomy (n = 1), and facial cutaneous malignancy resection (n = 1). Notably, 24 out of 26 surgeries achieved well-documented negative final margin statuses. The median number of inadequate margins ("margins at-risk") per case was 1.5 (range 0-6). The median number of supplemental tissue samples harvested per case was two (range 0-13).
conclusionsMV3D enhances surgical pathology documentation by consolidating precise anatomic orientation, clear margin reconciliation, and narrative summaries offered by the surgeon and pathologist into one platform to aid in the treatment of head and neck cancer. MV3D has the potential to improve margin reporting, care coordination, adjuvant treatment planning, and personalized cancer management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.